CAR-monocytes for the Treatment of HER2 Overexpressing Solid Tumors
Clinical trial NCT06254807 · UNKNOWN
Trial details
- NCT number
- NCT06254807
- Sponsor
- Carisma Therapeutics Inc
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-08
- Primary completion
- 2025-03-31
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.